ASHLAND INC.

(ASH)
  Report
Delayed Nyse  -  04:00 2022-08-15 pm EDT
107.08 USD   +0.61%
08/09Ashland Global Holdings Sells Land in Ajax, Canada to Sunray Group of Hotels for $9.6 Million
MT
08/08Ashland completes sale of land located in Ajax, Canada to Sunray Group of Hotels Inc, for CAD $12.25 million
AQ
08/08Ashland board authorizes quarterly dividend
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ashland Board appoints Steve D. Bishop, former chief executive officer, Procter and Gamble consumer health care, and Suzan F. Harrison, former president, Colgate-Palmolive global oral care as new directors effective July 1, 2022

06/13/2022 | 07:53am EDT

WILMINGTON - Ashland Global Holdings Inc. (NYSE: ASH) today announced the appointment of two new directors to its Board as of July 1, 2022: Steve Bishop, former chief executive officer, Procter and Gamble (P&G) consumer health care, and Suzan Harrison, former president, Colgate-Palmolive global oral care.

William Dempsey who has served as a director since 2016, and Ricky Sandler, who joined the board in 2020 have decided not to stand for re-election at Ashland's Annual Shareholders Meeting in January 2023.

Dempsey is the former executive vice president, global pharmaceuticals, Abbott Laboratories and the current chair of the Board's governance and nominating committee. He is also a member of the environment, health, safety and quality committee. Sandler is the founder and chief executive officer and chief investment officer of Eminence Capital. He is a member of both the audit and governance and nominating committee.

To allow for an orderly transition, the addition of Bishop and Harrison temporarily increases the size of the Board from nine to 11 members until the next Annual Shareholders Meeting in January 2023.

Steve Bishop is the recently retired chief executive officer of P&G consumer health care. In this capacity, he led the $11 billion consumer health care reportable unit. Previously, he served in president or group president roles across other P&G global operating units. He is a disciplined, results oriented leader who has a deep passion for innovation. As a mentor to several executives, he also supported the personal development of women and minorities and enabled broader executive level diversity in the company. Bishop is a graduate of Purdue University, where he obtained a Bachelor of Science degree in Agricultural Economics.

Suzan Harrison has held a variety of leadership positions at the Colgate-Palmolive Company. She was named president, global oral care in 2011, a position she held until her retirement in 2019. Previously, she was president, Hill's Pet Nutrition Inc. North America, and held other senior leadership positions, including vice president, marketing, for Colgate U.S., and vice president and general manager of Colgate Oral Pharmaceuticals, North America and Europe. She has strong operational experience in consumer products and a passion for sustainability. Harrison is a member of the Board of Directors of WestRock Company, and ADM where she chairs the Sustainability and Social Responsibility committee. Harrison holds a Master of Business Administration degree from New York University and a Bachelor of Science degree from Binghamton University.

'I am excited to welcome Steve and Suzan as new directors to the Ashland Board, and I am confident they will provide valuable perspectives as we continue to execute our strategy, drive profitability, and enhance value for our shareholders,' said Guillermo Novo, chair and chief executive officer, Ashland.

About Ashland

Ashland Global Holdings Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceuticals. Approximately 3,800 passionate, tenacious solvers - from renowned scientists and research chemists to talented engineers and plant operators - thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries.

Contact:

Seth A. Mrozek

Tel: +1 (302) 594-5010

Email: samrozek@ashland.com

(C) 2022 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
ASHLAND INC. 0.61% 107.08 Delayed Quote.-0.54%
COLGATE-PALMOLIVE COMPANY 1.18% 81.24 Delayed Quote.-4.80%
PROCTER & GAMBLE COMPANY 1.29% 148.56 Delayed Quote.-9.18%
All news about ASHLAND INC.
08/09Ashland Global Holdings Sells Land in Ajax, Canada to Sunray Group of Hotels for $9.6 M..
MT
08/08Ashland completes sale of land located in Ajax, Canada to Sunray Group of Hotels Inc, f..
AQ
08/08Ashland board authorizes quarterly dividend
AQ
08/08Ashland Maintains Dividend at $0.335/Share; Payable on Sept. 15 to Shareholders of Reco..
MT
08/06Ashland Inc. Declares Quarterly Cash Dividend, Payable on September 15, 2022
CI
08/05Ashland board authorizes quarterly dividend
AQ
08/05ASHLAND INC. Change in Directors or Principal Officers (form 8-K/A)
AQ
08/05Ashland Inc. Announces Executive Appointments
CI
08/01ASHLAND GLOBAL : Amendments to Articles of Incorporation/Bylaws/Change in Fiscal Year - Fo..
PU
08/01ASHLAND INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial ..
AQ
More news
Analyst Recommendations on ASHLAND INC.
More recommendations
Financials (USD)
Sales 2022 2 384 M - -
Net income 2022 912 M - -
Net Debt 2022 613 M - -
P/E ratio 2022 6,62x
Yield 2022 1,19%
Capitalization 5 797 M 5 797 M -
EV / Sales 2022 2,69x
EV / Sales 2023 2,62x
Nbr of Employees 3 800
Free-Float 99,6%
Chart ASHLAND INC.
Duration : Period :
Ashland Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASHLAND INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 107,08 $
Average target price 124,40 $
Spread / Average Target 16,2%
EPS Revisions
Managers and Directors
Guillermo Novo Chairman & Chief Executive Officer
J. Kevin Willis Chief Financial Officer & Senior Vice President
Osama M. Musa Chief Technology Officer & Senior Vice President
Brendan Matthew Cummins Independent Director
William G. Dempsey Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ASHLAND INC.-0.54%5 797
SHIN-ETSU CHEMICAL CO., LTD-12.53%53 439
BASF SE-28.68%40 693
DUPONT DE NEMOURS, INC.-22.38%31 407
PIDILITE INDUSTRIES LIMITED6.57%16 754
FMC CORPORATION1.91%14 141